OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A cooperative nano-CRISPR scaffold potentiates immunotherapy via activation of tumour-intrinsic pyroptosis
Ning Wang, Chao Liu, Yingjie Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy
Fengqiao Li, Xue‐Qing Zhang, William Ho, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 57

Bioorthogonal Disruption of Pyroptosis Checkpoint for High-Efficiency Pyroptosis Cancer Therapy
Bin Zhang, Zhengwei Liu, Jiawei Zhu, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 30, pp. 16658-16668
Closed Access | Times Cited: 53

Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
Heng Dong, Qiang Li, Yu Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 18
Open Access | Times Cited: 45

Mitochondria-Targeting Type-I Photodrug: Harnessing Caspase-3 Activity for Pyroptotic Oncotherapy
Zhigao Yi, Xujuan Qin, Li Zhang, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 13, pp. 9413-9421
Closed Access | Times Cited: 25

Advances and applications of nanoparticles in cancer therapy
Xianzhou Huang, Tao He, Xiuqi Liang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 17

Recent strategies for evoking immunogenic Pyroptosis in antitumor immunotherapy
Zhangxin He, Dexiang Feng, Chaoji Zhang, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 375-394
Open Access | Times Cited: 15

Chemoimmunotherapeutic Nanogel for Pre- and Postsurgical Treatment of Malignant Melanoma by Reprogramming Tumor-Associated Macrophages
Lu Tang, Cong Fu, Hening Liu, et al.
Nano Letters (2024) Vol. 24, Iss. 5, pp. 1717-1728
Closed Access | Times Cited: 15

Cryo-shocked tumor cells deliver CRISPR-Cas9 for lung cancer regression by synthetic lethality
F Liu, Minhang Xin, Huiheng Feng, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 13

Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity
Yongjuan Li, Yichen Guo, Kaixin Zhang, et al.
Advanced Science (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 21

Advancing Precision: A Controllable Self-Synergistic Nanoplatform Initiating Pyroptosis-Based Immunogenic Cell Death Cascade for Targeted Tumor Therapy
Weiji Qin, Lei Qiao, Qian Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 2, pp. 1582-1598
Closed Access | Times Cited: 12

Nanoplatform‐Based In Vivo Gene Delivery Systems for Cancer Therapy
Rui Luo, Hao Le, Qinjie Wu, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 12

Metformin-based nanomedicines for reprogramming tumor immune microenvironment
Jieyu Liu, Xiaoling Li, Yinggang Li, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 993-1016
Closed Access | Times Cited: 11

Hypoxia-accelerating pyroptosis nanoinducers for promoting image-guided cancer immunotherapy
Dongfang Liu, Mengyun Liang, Yongyou Tao, et al.
Biomaterials (2024) Vol. 309, pp. 122610-122610
Closed Access | Times Cited: 10

Gene engineered exosome reverses T cell exhaustion in cancer immunotherapy
Peishan Li, Ying Xie, Jinling Wang, et al.
Bioactive Materials (2024) Vol. 34, pp. 466-481
Open Access | Times Cited: 9

Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment
Shiyao Zhou, Yingjie Li, Qinjie Wu, et al.
MedComm – Biomaterials and Applications (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 8

Dual-Coordinated atomically dispersed Pt nanozymes evoke efficient pyroptosis for cancer immunotherapy
Jingqi Chen, Yanping Tang, Lin Yan, et al.
Chemical Engineering Journal (2024) Vol. 483, pp. 149312-149312
Closed Access | Times Cited: 7

The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles
Yixiang Hu, Ya Liu, Lijuan Zong, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 16

Harnessing Pyroptosis for Cancer Immunotherapy
Christopher M. Bourne, Cornelius Y. Taabazuing
Cells (2024) Vol. 13, Iss. 4, pp. 346-346
Open Access | Times Cited: 6

A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy
Mengyu Chang, Man Wang, Bin Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 11, pp. 8143-8156
Closed Access | Times Cited: 6

Hydroxyethyl starch-based self-reinforced nanomedicine inhibits both glutathione and thioredoxin antioxidant pathways to boost reactive oxygen species-powered immunotherapy
Yuxuan Xiong, Zhengtao Yong, Qingfu Zhao, et al.
Biomaterials (2024) Vol. 311, pp. 122673-122673
Closed Access | Times Cited: 6

A T‐Cell Inspired Sonoporation System Enhances Low‐Dose X‐Ray‐Mediated Pyroptosis and Radioimmunotherapy Efficacy by Restoring Gasdermin‐E Expression
Hao Yin, Xiaoqu Hu, Congying Xie, et al.
Advanced Materials (2024) Vol. 36, Iss. 26
Closed Access | Times Cited: 5

A hypoxia-activated and microenvironment-remodeling nanoplatform for multifunctional imaging and potentiated immunotherapy of cancer
Jianwen Song, He Wang, Xue Meng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5

A photo-accelerated nanoplatform for image-guided synergistic chemo-photodynamic therapy
Di Zhang, Xu He, Xiaoying Kang, et al.
Chinese Chemical Letters (2025), pp. 110942-110942
Closed Access

Page 1 - Next Page

Scroll to top